MINYANVILLE ORIGINAL Some drug and biotech companies including several industry leaders hope to win US approvals for potential blockbuster treatments during the first three months of 2013. The Food and Drug Administration will make a number of decisions in the first quarter regarding market clearance for experimental medicines. Here are five potential drug approvals scheduled for that period and the reason they’re key to strategies for the companies who developed the therapies. The descriptions are listed in chronological order. The date represents the deadline for the FDA to make a ruling on each drug. Some of these dates can ...